Expand All Collapse All
IID-11.4 Increase the vaccination coverage level of 3 doses of human papillomavirus (HPV) vaccine for females by age 13 to 15 years
About the Data: National
Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of females aged 13 to 15 years receiving at least 3 doses of the human papillomavirus (HPV) vaccine
Number of females aged 13 to 15 years
From the 2013 National Immunization Survey-Teen Provider-Immunization History Questionnaire:
[NUMERATOR:]
Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.
The National Immunization Survey-Teen (NIS-Teen) collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit-dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.
In 2007, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination for females age 11–12 years and catch-up vaccination for females aged 13–26 years who have not been previously vaccinated. The vaccination may be initiated as early as nine years of age and should be administered before potential exposure to HPV through sexual contact.
This measure tracks the proportion of female adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent or bivalent human papillomavirus vaccine.
About the Data: State
Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.
Number of females aged 13 to 15 years receiving at least 3 doses of the human papillomavirus (HPV) vaccine
Number of females aged 13 to 15 years
From the 2013 National Immunization Survey-Teen Provider-Immunization History Questionnaire:
[NUMERATOR:]
Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.
The National Immunization Survey-Teen (NIS-Teen) collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit-dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.
In 2007, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination for females age 11–12 years and catch-up vaccination for females aged 13–26 years who have not been previously vaccinated. The vaccination may be initiated as early as nine years of age and should be administered before potential exposure to HPV through sexual contact.
This measure tracks the proportion of female adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent or bivalent human papillomavirus vaccine.
Revision History
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
References
Additional resources about the objective
- Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6].
